{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:24:37Z","timestamp":1791228277532,"version":"4.1.0"},"reference-count":95,"publisher":"Oxford University Press (OUP)","issue":"D1","license":[{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["82373790"],"award-info":[{"award-number":["82373790"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["22220102001"],"award-info":[{"award-number":["22220102001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["81872798"],"award-info":[{"award-number":["81872798"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["U1909208"],"award-info":[{"award-number":["U1909208"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LR21H300001"],"award-info":[{"award-number":["LR21H300001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundamental Research Funds for Central Universities","award":["2018QNA7023"],"award-info":[{"award-number":["2018QNA7023"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"publisher","award":["2022YFC3400501"],"award-info":[{"award-number":["2022YFC3400501"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Double Top-Class University","award":["181201*194232101"],"award-info":[{"award-number":["181201*194232101"]}]},{"name":"Key R&D Program of Zhejiang","award":["2020C03010"],"award-info":[{"award-number":["2020C03010"]}]},{"name":"Westlake Laboratory"},{"name":"Leading Talent of the \u2018Ten Thousand Plan\u2019 National High-Level Talents Special Support Plan of China"},{"name":"Alibaba-Zhejiang University Joint Research Center of Future Digital Healthcare"},{"name":"Alibaba Cloud"},{"DOI":"10.13039\/501100004835","name":"Zhejiang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Peptide\u2013drug conjugates (PDCs) have emerged as a promising class of targeted therapeutics with substantial pharmaceutical advantages and market potentials, which is a combination of a peptide (selective to the disease-relevant target), a linker (stable in circulation but cleavable at target site)\u00a0and a cytotoxic\/radioactive drug (efficacious\/traceable for disease). Among existing PDCs, those based on radiopharmaceuticals (a.k.a. radioactive drugs) are valued due to their accurate imaging and targeted destruction of disease sites. It's demanded to accumulate the biological activity and pharmaceutical information of PDCs. Herein, a database PDCdb was thus constructed to systematically describe these valuable data. Particularly, biological activities for 2036 PDCs were retrieved from literatures, which resulted in 1684, 613\u00a0and 2753 activity data generated based on clinical trial, animal model\u00a0and cell line, respectively. Furthermore, the pharmaceutical information for all 2036 PDCs was collected, which gave the diverse data of (a) ADME property, plasma half-life\u00a0and administration approach of a PDC and (b) chemical modification, primary target, mode of action, conjugating feature of the constituent peptide\/linker\/drug. In sum, PDCdb systematically provided the biological activities and pharmaceutical information for the most comprehensive list of PDCs among the available databases, which was expected to attract broad interest from related communities and could be freely accessible at: https:\/\/idrblab.org\/PDCdb\/<\/jats:p>","DOI":"10.1093\/nar\/gkae859","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T10:55:53Z","timestamp":1727952953000},"page":"D1476-D1485","source":"Crossref","is-referenced-by-count":10,"title":["PDCdb: the biological activity and pharmaceutical information of peptide\u2013drug conjugate (PDC)"],"prefix":"10.1093","volume":"53","author":[{"given":"Xiuna","family":"Sun","sequence":"first","affiliation":[{"name":"School of Pharmacy, Hebei Medical University , Shijiazhuang\u00a0 050017 ,","place":["China"]},{"name":"College of Pharmaceutical Sciences, Department of Otolaryngology Head and Neck Surgery, Sir Run Run Shaw Hospital, The Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University , Hangzhou\u00a0 310058 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyang","family":"Li","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, Department of Otolaryngology Head and Neck Surgery, Sir Run Run Shaw Hospital, The Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University , Hangzhou\u00a0 310058 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Chen","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, Department of Otolaryngology Head and Neck Surgery, Sir Run Run Shaw Hospital, The Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University , Hangzhou\u00a0 310058 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Hebei Medical University , Shijiazhuang\u00a0 050017 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangle","family":"Wei","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, Department of Otolaryngology Head and Neck Surgery, Sir Run Run Shaw Hospital, The Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University , Hangzhou\u00a0 310058 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangwei","family":"Xu","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, Department of Otolaryngology Head and Neck Surgery, Sir Run Run Shaw Hospital, The Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University , Hangzhou\u00a0 310058 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liao","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, Department of Otolaryngology Head and Neck Surgery, Sir Run Run Shaw Hospital, The Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University , Hangzhou\u00a0 310058 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanghao","family":"Jiang","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, Department of Otolaryngology Head and Neck Surgery, Sir Run Run Shaw Hospital, The Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University , Hangzhou\u00a0 310058 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichao","family":"Ge","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, Department of Otolaryngology Head and Neck Surgery, Sir Run Run Shaw Hospital, The Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University , Hangzhou\u00a0 310058 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Zheng","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, Department of Otolaryngology Head and Neck Surgery, Sir Run Run Shaw Hospital, The Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University , Hangzhou\u00a0 310058 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Li","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, Department of Otolaryngology Head and Neck Surgery, Sir Run Run Shaw Hospital, The Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University , Hangzhou\u00a0 310058 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Wu","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, Department of Otolaryngology Head and Neck Surgery, Sir Run Run Shaw Hospital, The Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University , Hangzhou\u00a0 310058 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyin","family":"Luo","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, Department of Otolaryngology Head and Neck Surgery, Sir Run Run Shaw Hospital, The Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University , Hangzhou\u00a0 310058 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luo","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences , Hangzhou\u00a0 310005 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowu","family":"Dong","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, Department of Otolaryngology Head and Neck Surgery, Sir Run Run Shaw Hospital, The Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University , Hangzhou\u00a0 310058 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7131-6251","authenticated-orcid":false,"given":"Mang","family":"Xiao","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, Department of Otolaryngology Head and Neck Surgery, Sir Run Run Shaw Hospital, The Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University , Hangzhou\u00a0 310058 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6364-7843","authenticated-orcid":false,"given":"Lianyi","family":"Han","sequence":"additional","affiliation":[{"name":"Greater Bay Area Institute of Precision Medicine (Guangzhou), School of Life Sciences, Fudan University , Shanghai\u00a0 315211 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingzhong","family":"Jia","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Hebei Medical University , Shijiazhuang\u00a0 050017 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8069-0053","authenticated-orcid":false,"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Hebei Medical University , Shijiazhuang\u00a0 050017 ,","place":["China"]},{"name":"College of Pharmaceutical Sciences, Department of Otolaryngology Head and Neck Surgery, Sir Run Run Shaw Hospital, The Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University , Hangzhou\u00a0 310058 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"key":"2025010610511472400_B1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/d41573-023-00001-3","article-title":"2022 FDA approvals","volume":"22","author":"Mullard","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"2025010610511472400_B2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","article-title":"Trends in peptide drug discovery","volume":"20","author":"Muttenthaler","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"2025010610511472400_B3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"2025010610511472400_B4","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1021\/cr500171e","article-title":"Lutetium-177 therapeutic radiopharmaceuticals: linking chemistry, radiochemistry, and practical applications","volume":"115","author":"Banerjee","year":"2015","journal-title":"Chem. Rev."},{"key":"2025010610511472400_B5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.annonc.2023.03.001","article-title":"Next generation radiotheranostics promoting precision medicine","volume":"34","author":"Pomykala","year":"2023","journal-title":"Ann. Oncol."},{"key":"2025010610511472400_B6","doi-asserted-by":"crossref","first-page":"D1263","DOI":"10.1093\/nar\/gkac812","article-title":"DRESIS: the first comprehensive landscape of drug resistance information","volume":"51","author":"Sun","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"2025010610511472400_B7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.apsb.2022.07.020","article-title":"Peptide-drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?","volume":"13","author":"Fu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"2025010610511472400_B8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.tips.2021.07.001","article-title":"Peptide-drug conjugate-based novel molecular drug delivery system in cancer","volume":"42","author":"Zhu","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"2025010610511472400_B9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.addr.2017.01.006","article-title":"Improving drug-like properties of insulin and GLP-1 via molecule design and formulation and improving diabetes management with device & drug delivery","volume":"112","author":"Pechenov","year":"2017","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"2025010610511472400_B10","doi-asserted-by":"crossref","first-page":"121783","DOI":"10.1016\/j.biomaterials.2022.121783","article-title":"Sustained potentiation of bystander killing via PTEN-loss driven macropinocytosis targeted peptide\u2013drug conjugate therapy in metastatic triple-negative breast cancer","volume":"289","author":"Cho","year":"2022","journal-title":"Biomaterials"},{"key":"2025010610511472400_B11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.addr.2016.06.015","article-title":"Peptide-drug conjugates as effective prodrug strategies for targeted delivery","volume":"110-111","author":"Wang","year":"2017","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"2025010610511472400_B12","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41571-022-00652-y","article-title":"Radiotheranostics in oncology: current challenges and emerging opportunities","volume":"19","author":"Bodei","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2025010610511472400_B13","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1016\/j.apsb.2023.02.013","article-title":"Research advances in peptide\u2013drug conjugates","volume":"13","author":"Gong","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"2025010610511472400_B14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.eng.2023.01.014","article-title":"Artificial intelligence in pharmaceutical sciences","volume":"27","author":"Lu","year":"2023","journal-title":"Engineering"},{"key":"2025010610511472400_B15","doi-asserted-by":"crossref","first-page":"D1233","DOI":"10.1093\/nar\/gkaa755","article-title":"INTEDE: interactome of drug-metabolizing enzymes","volume":"49","author":"Yin","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"2025010610511472400_B16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/bib\/bby130","article-title":"Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs","volume":"21","author":"Li","year":"2020","journal-title":"Brief. Bioinform."},{"key":"2025010610511472400_B17","doi-asserted-by":"crossref","first-page":"D1417","DOI":"10.1093\/nar\/gkab1013","article-title":"VARIDT 2.0: structural variability of drug transporter","volume":"50","author":"Fu","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"2025010610511472400_B18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13059-024-03166-1","article-title":"AnnoPRO: a strategy for protein function annotation based on multi-scale protein representation and a hybrid deep learning of dual-path encoding","volume":"25","author":"Zheng","year":"2024","journal-title":"Genome Biol."},{"key":"2025010610511472400_B19","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1093\/nar\/gkad929","article-title":"A task-specific encoding algorithm for RNAs and RNA-associated interactions based on convolutional autoencoder","volume":"51","author":"Wang","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"2025010610511472400_B20","doi-asserted-by":"crossref","first-page":"e2207061","DOI":"10.1002\/advs.202207061","article-title":"ANPELA: significantly enhanced quantification tool for cytometry-based single-cell proteomics","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"2025010610511472400_B21","first-page":"e2201859","article-title":"De novo design of an androgen receptor dna binding domain-targeted peptide protac for prostate cancer therapy","volume":"9","author":"Ma","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"key":"2025010610511472400_B22","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/bib\/bbz049","article-title":"Consistent gene signature of schizophrenia identified by a novel feature selection strategy from comprehensive sets of transcriptomic data","volume":"21","author":"Yang","year":"2020","journal-title":"Brief. Bioinform."},{"key":"2025010610511472400_B23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1021\/acschemneuro.1c00694","article-title":"Molecular mechanism for the allosteric inhibition of the human serotonin transporter by antidepressant escitalopram","volume":"13","author":"Xue","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"2025010610511472400_B24","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"2025010610511472400_B25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/M15-2658","article-title":"ClinicalTrials.gov and Drugs@FDA: a comparison of results reporting for new drug approval trials","volume":"165","author":"Schwartz","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"2025010610511472400_B26","doi-asserted-by":"crossref","first-page":"D1276","DOI":"10.1093\/nar\/gkac1085","article-title":"DrugCentral 2023 extends human clinical data and integrates veterinary drugs","volume":"51","author":"Avram","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"2025010610511472400_B27","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"2025010610511472400_B28","doi-asserted-by":"crossref","first-page":"D1307","DOI":"10.1093\/nar\/gkab918","article-title":"NCATS Inxight drugs: a comprehensive and curated portal for translational research","volume":"50","author":"Siramshetty","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"2025010610511472400_B29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41597-022-01287-5","article-title":"HORDB: a comprehensive database of peptide hormones","volume":"9","author":"Zhu","year":"2022","journal-title":"Sci. Data"},{"key":"2025010610511472400_B30","doi-asserted-by":"crossref","first-page":"D1098","DOI":"10.1093\/nar\/gkv1266","article-title":"CPPsite 2.0: a repository of experimentally validated cell-penetrating peptides","volume":"44","author":"Agrawal","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"2025010610511472400_B31","doi-asserted-by":"crossref","first-page":"D1087","DOI":"10.1093\/nar\/gkv1278","article-title":"APD3: the antimicrobial peptide database as a tool for research and education","volume":"44","author":"Wang","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"2025010610511472400_B32","doi-asserted-by":"crossref","first-page":"D1102","DOI":"10.1093\/nar\/gkaa950","article-title":"ConjuPepDB: a database of peptide\u2013drug conjugates","volume":"49","author":"Balogh","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"2025010610511472400_B33","doi-asserted-by":"crossref","first-page":"8064","DOI":"10.1038\/s41467-023-43718-w","article-title":"Design and structural validation of peptide\u2013drug conjugate ligands of the kappa-opioid receptor","volume":"14","author":"Muratspahic","year":"2023","journal-title":"Nat. Commun."},{"key":"2025010610511472400_B34","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.3390\/molecules27196656","article-title":"Comparing variants of the cell-penetrating peptide sC18 to design peptide\u2013drug conjugates","volume":"27","author":"Grabeck","year":"2022","journal-title":"Molecules"},{"key":"2025010610511472400_B35","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.3390\/ijms20174184","article-title":"Characterization of tachyplesin peptides and their cyclized analogues to improve antimicrobial and anticancer properties","volume":"20","author":"Vernen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"2025010610511472400_B36","doi-asserted-by":"crossref","first-page":"121985","DOI":"10.1016\/j.biomaterials.2022.121985","article-title":"An injectable PEG-like conjugate forms a subcutaneous depot and enables sustained delivery of a peptide drug","volume":"294","author":"Ozer","year":"2023","journal-title":"Biomaterials"},{"key":"2025010610511472400_B37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41573-019-0053-0","article-title":"Advances in oral peptide therapeutics","volume":"19","author":"Drucker","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"2025010610511472400_B38","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.drudis.2021.01.022","article-title":"Converting peptides into drugs targeting intracellular protein-protein interactions","volume":"26","author":"Philippe","year":"2021","journal-title":"Drug Discov Today"},{"key":"2025010610511472400_B39","doi-asserted-by":"crossref","first-page":"D1042","DOI":"10.1093\/nar\/gkz779","article-title":"VARIDT 1.0: variability of drug transporter database","volume":"48","author":"Yin","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"2025010610511472400_B40","doi-asserted-by":"crossref","first-page":"D1355","DOI":"10.1093\/nar\/gkad1013","article-title":"INTEDE 2.0: the metabolic roadmap of drugs","volume":"52","author":"Zhang","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"2025010610511472400_B41","doi-asserted-by":"crossref","first-page":"9842","DOI":"10.1021\/acs.jmedchem.3c00631","article-title":"Synthesis and evaluation of a monomethyl auristatin E horizontal line integrin alpha(v)beta(6) binding peptide\u2013drug conjugate for tumor targeted drug delivery","volume":"66","author":"Davis","year":"2023","journal-title":"J. Med. Chem."},{"key":"2025010610511472400_B42","doi-asserted-by":"crossref","first-page":"121139","DOI":"10.1016\/j.biomaterials.2021.121139","article-title":"Targeted in situ self-assembly augments peptide drug conjugate cell-entry efficiency","volume":"278","author":"Wang","year":"2021","journal-title":"Biomaterials"},{"key":"2025010610511472400_B43","doi-asserted-by":"crossref","first-page":"bbac135","DOI":"10.1093\/bib\/bbac135","article-title":"Structured sparse regularized TSK fuzzy system for predicting therapeutic peptides","volume":"23","author":"Guo","year":"2022","journal-title":"Brief Bioinform"},{"key":"2025010610511472400_B44","doi-asserted-by":"crossref","first-page":"D1097","DOI":"10.1093\/nar\/gkad831","article-title":"ADCdb: the database of antibody-drug conjugates","volume":"52","author":"Shen","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"2025010610511472400_B45","doi-asserted-by":"crossref","first-page":"8324","DOI":"10.1021\/acs.jmedchem.3c00382","article-title":"Identification of a pH-responsive peptide-paclitaxel conjugate as a novel drug with improved therapeutic potential","volume":"66","author":"Rizvi","year":"2023","journal-title":"J. Med. Chem."},{"key":"2025010610511472400_B46","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3762\/bjoc.14.80","article-title":"On the design principles of peptide\u2013drug conjugates for targeted drug delivery to the malignant tumor site","volume":"14","author":"Vrettos","year":"2018","journal-title":"Beilstein J. Org. Chem."},{"key":"2025010610511472400_B47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4155\/bio-2020-0256","article-title":"Development of a LC-MS\/MS method for the quantification of toxic payload DM1 cleaved from BT1718 in a phase I study","volume":"13","author":"Gowland","year":"2021","journal-title":"Bioanalysis"},{"key":"2025010610511472400_B48","doi-asserted-by":"crossref","first-page":"7564","DOI":"10.1021\/jm400647r","article-title":"Novel peptide-doxorubucin conjugates for targeting breast cancer cells including the multidrug resistant cells","volume":"56","author":"Soudy","year":"2013","journal-title":"J. Med. Chem."},{"key":"2025010610511472400_B49","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1021\/acs.molpharmaceut.3c00189","article-title":"Peptide-drug conjugate targeting keratin 1 inhibits triple-negative breast cancer in mice","volume":"20","author":"Ziaei","year":"2023","journal-title":"Mol Pharm"},{"key":"2025010610511472400_B50","doi-asserted-by":"crossref","first-page":"0240","DOI":"10.34133\/research.0240","article-title":"A transformer-based ensemble framework for the prediction of protein-protein interaction sites","volume":"6","author":"Mou","year":"2023","journal-title":"Research"},{"key":"2025010610511472400_B51","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-020-2168-1","article-title":"Multispecific drugs herald a new era of biopharmaceutical innovation","volume":"580","author":"Deshaies","year":"2020","journal-title":"Nature"},{"key":"2025010610511472400_B52","doi-asserted-by":"crossref","first-page":"D1288","DOI":"10.1093\/nar\/gkac813","article-title":"DrugMAP: molecular atlas and pharma-information of all drugs","volume":"51","author":"Li","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"2025010610511472400_B53","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1470-2045(23)00158-4","article-title":"Health-related quality of life and pain outcomes with [(177)Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial","volume":"24","author":"Fizazi","year":"2023","journal-title":"Lancet Oncol."},{"key":"2025010610511472400_B54","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2022.06.001","article-title":"18F-PSMA-11 as an attractive 68Ga-PSMA-11 alternative for prostate cancer imaging","volume":"82","author":"van\u00a0Leeuwen","year":"2022","journal-title":"Eur. Urol."},{"key":"2025010610511472400_B55","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41586-024-07181-x","article-title":"Couple-close construction of polycyclic rings from diradicals","volume":"628","author":"Long","year":"2024","journal-title":"Nature"},{"key":"2025010610511472400_B56","first-page":"2823","article-title":"Inhibition of colon cancer cell growth by nanoemulsion carrying gold nanoparticles and lycopene","volume":"10","author":"Huang","year":"2015","journal-title":"Int J Nanomedicine"},{"key":"2025010610511472400_B57","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1021\/acs.jmedchem.0c01530","article-title":"Peptide-drug conjugates with different linkers for cancer therapy","volume":"64","author":"Alas","year":"2021","journal-title":"J. Med. Chem."},{"key":"2025010610511472400_B58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41596-021-00636-9","article-title":"Optimization of metabolomic data processing using NOREVA","volume":"17","author":"Fu","year":"2022","journal-title":"Nat. Protoc."},{"key":"2025010610511472400_B59","doi-asserted-by":"crossref","first-page":"W436","DOI":"10.1093\/nar\/gkaa258","article-title":"NOREVA: enhanced normalization and evaluation of time-course and multi-class metabolomic data","volume":"48","author":"Yang","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"2025010610511472400_B60","doi-asserted-by":"crossref","first-page":"104023","DOI":"10.1016\/j.jprot.2020.104023","article-title":"MMEASE: online meta-analysis of metabolomic data by enhanced metabolite annotation, marker selection and enrichment analysis","volume":"232","author":"Yang","year":"2021","journal-title":"J. Proteomics"},{"key":"2025010610511472400_B61","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1200\/JCO.22.00176","article-title":"Neuroendocrine tumors and peptide receptor radionuclide therapy: when is the right time?","volume":"40","author":"Hope","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"2025010610511472400_B62","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1021\/jm001065f","article-title":"Novel peptide conjugates for tumor-specific chemotherapy","volume":"44","author":"Langer","year":"2001","journal-title":"J. Med. Chem."},{"key":"2025010610511472400_B63","doi-asserted-by":"crossref","first-page":"W162","DOI":"10.1093\/nar\/gkx449","article-title":"NOREVA: normalization and evaluation of MS-based metabolomics data","volume":"45","author":"Li","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"2025010610511472400_B64","doi-asserted-by":"crossref","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","article-title":"TTD: therapeutic target database describing target druggability information","volume":"52","author":"Zhou","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"2025010610511472400_B65","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: towards direct deposition of bioassay data","volume":"47","author":"Mendez","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2025010610511472400_B66","doi-asserted-by":"crossref","first-page":"11843","DOI":"10.1021\/acs.jmedchem.3c00426","article-title":"Development of a selective peptide kappa-opioid receptor antagonist by late-stage functionalization with cysteine staples","volume":"66","author":"Muratspahic","year":"2023","journal-title":"J. Med. Chem."},{"key":"2025010610511472400_B67","doi-asserted-by":"crossref","first-page":"20460","DOI":"10.1021\/jacs.9b11194","article-title":"Is the mirror image a true reflection? Intrinsic membrane chirality modulates peptide binding","volume":"141","author":"Henriques","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"2025010610511472400_B68","doi-asserted-by":"crossref","first-page":"120347","DOI":"10.1016\/j.biomaterials.2020.120347","article-title":"Cancer-specific drug-drug nanoparticles of pro-apoptotic and cathepsin B-cleavable peptide-conjugated doxorubicin for drug-resistant cancer therapy","volume":"261","author":"Shim","year":"2020","journal-title":"Biomaterials"},{"key":"2025010610511472400_B69","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jconrel.2024.04.011","article-title":"A novel peptide\u2013drug conjugate for glioma-targeted drug delivery","volume":"369","author":"Zhou","year":"2024","journal-title":"J. Control Release"},{"key":"2025010610511472400_B70","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1039\/D0BM01001D","article-title":"A peptide\u2013drug hydrogel to enhance the anti-cancer activity of chlorambucil","volume":"8","author":"Guo","year":"2020","journal-title":"Biomater. Sci."},{"key":"2025010610511472400_B71","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.biopha.2015.01.027","article-title":"Design and biological activity of epidermal growth factor receptor-targeted peptide doxorubicin conjugate","volume":"70","author":"Fan","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"2025010610511472400_B72","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1039\/C7CS00793K","article-title":"Peptide-based nanoprobes for molecular imaging and disease diagnostics","volume":"47","author":"Zhang","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"2025010610511472400_B73","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1021\/acs.bioconjchem.9b00755","article-title":"Targeting triple negative breast cancer cells with novel cytotoxic peptide-doxorubicin conjugates","volume":"30","author":"Ziaei","year":"2019","journal-title":"Bioconjug. Chem."},{"key":"2025010610511472400_B74","doi-asserted-by":"crossref","first-page":"12264","DOI":"10.1021\/acs.analchem.3c01057","article-title":"PepDRED: de novo peptide design with strong binding affinity for target protein","volume":"95","author":"Azmat","year":"2023","journal-title":"Anal. Chem."},{"key":"2025010610511472400_B75","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jconrel.2015.04.037","article-title":"A cleavable cytolysin-neuropeptide Y bioconjugate enables specific drug delivery and demonstrates intracellular mode of action","volume":"209","author":"Ahrens","year":"2015","journal-title":"J. Control Release"},{"key":"2025010610511472400_B76","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1021\/am404729c","article-title":"Surface-conjugated antimicrobial peptide leucocin a displays high binding to pathogenic gram-positive bacteria","volume":"6","author":"Etayash","year":"2014","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2025010610511472400_B77","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3390\/pharmaceutics13040481","article-title":"Peptide-based strategies for targeted tumor treatment and imaging","volume":"13","author":"Ayo","year":"2021","journal-title":"Pharmaceutics"},{"key":"2025010610511472400_B78","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/acschemneuro.7b00490","article-title":"What contributes to serotonin-norepinephrine reuptake inhibitors' dual-targeting mechanism? The key role of transmembrane domain 6 in human serotonin and norepinephrine transporters revealed by molecular dynamics simulation","volume":"9","author":"Xue","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"2025010610511472400_B79","doi-asserted-by":"crossref","first-page":"bbac040","DOI":"10.1093\/bib\/bbac040","article-title":"POSREG: proteomic signature discovered by simultaneously optimizing its reproducibility and generalizability","volume":"23","author":"Li","year":"2022","journal-title":"Brief Bioinform"},{"key":"2025010610511472400_B80","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/bib\/bby127","article-title":"ANPELA: analysis and performance assessment of the label-free quantification workflow for metaproteomic studies","volume":"21","author":"Tang","year":"2020","journal-title":"Brief. Bioinform."},{"key":"2025010610511472400_B81","doi-asserted-by":"crossref","first-page":"bbac253","DOI":"10.1093\/bib\/bbac253","article-title":"ConSIG: consistent discovery of molecular signature from OMIC data","volume":"23","author":"Li","year":"2022","journal-title":"Brief. Bioinform."},{"key":"2025010610511472400_B82","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1158\/0008-5472.CAN-05-2591","article-title":"Targeting cell-impermeable prodrug activation to tumor microenvironment eradicates multiple drug-resistant neoplasms","volume":"66","author":"Wu","year":"2006","journal-title":"Cancer Res."},{"key":"2025010610511472400_B83","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3390\/pharmaceutics14020235","article-title":"The use of bioactive compounds in hyperglycemia- and amyloid fibrils-induced toxicity in type 2 diabetes and Alzheimer's disease","volume":"14","author":"Lupaescu","year":"2022","journal-title":"Pharmaceutics"},{"key":"2025010610511472400_B84","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3390\/pharmaceutics13050661","article-title":"Evaluation of a keratin 1 targeting peptide-doxorubicin conjugate in a mouse model of triple-negative breast cancer","volume":"13","author":"Saghaeidehkordi","year":"2021","journal-title":"Pharmaceutics"},{"key":"2025010610511472400_B85","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3390\/pharmaceutics14091910","article-title":"The TH1902 docetaxel peptide\u2013drug conjugate inhibits xenografts growth of human SORT1-positive ovarian and triple-negative breast cancer stem-like cells","volume":"14","author":"Demeule","year":"2022","journal-title":"Pharmaceutics"},{"key":"2025010610511472400_B86","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1021\/acs.jmedchem.3c00223","article-title":"Somatostatin receptor subtype-2 targeting system for specific delivery of temozolomide","volume":"67","author":"AghaAmiri","year":"2024","journal-title":"J. Med. Chem."},{"key":"2025010610511472400_B87","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1039\/D0NP00019A","article-title":"Cytotoxic and antitumor peptides as novel chemotherapeutics","volume":"38","author":"Luan","year":"2021","journal-title":"Nat. Prod. Rep."},{"key":"2025010610511472400_B88","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/s41551-020-0597-7","article-title":"Tumour sensitization via the extended intratumoural release of a STING agonist and camptothecin from a self-assembled hydrogel","volume":"4","author":"Wang","year":"2020","journal-title":"Nat Biomed Eng"},{"key":"2025010610511472400_B89","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.3390\/ijms24043106","article-title":"Influence of the drug position on bioactivity in angiopep-2-daunomycin conjugates","volume":"24","author":"Petho","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"2025010610511472400_B90","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3390\/pharmaceutics15010141","article-title":"Cell-penetrating dabcyl-containing tetraarginines with backbone aromatics as uptake enhancers","volume":"15","author":"Yousef","year":"2022","journal-title":"Pharmaceutics"},{"key":"2025010610511472400_B91","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1073\/pnas.1519960113","article-title":"Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis","volume":"113","author":"Thell","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2025010610511472400_B92","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.3390\/cancers14081877","article-title":"The peptide\u2013drug conjugate TH1902: a new sortilin receptor-mediated cancer therapeutic against ovarian and endometrial cancers","volume":"14","author":"Currie","year":"2022","journal-title":"Cancers"},{"key":"2025010610511472400_B93","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jconrel.2022.04.014","article-title":"Caspase-3 mediated switch therapy of self-triggered and long-acting prodrugs for metastatic TNBC","volume":"346","author":"Kim","year":"2022","journal-title":"J. Control Release"},{"key":"2025010610511472400_B94","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3390\/pharmaceutics12060576","article-title":"Phage display-based homing peptide-daunomycin conjugates for selective drug targeting to PANC-1 pancreatic cancer","volume":"12","author":"Dokus","year":"2020","journal-title":"Pharmaceutics"},{"key":"2025010610511472400_B95","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0140-6736(19)31205-X","article-title":"Icd-11","volume":"393","author":"Lancet","year":"2019","journal-title":"Lancet"}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/nar\/article-pdf\/53\/D1\/D1476\/59549038\/gkae859.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nar\/article-pdf\/53\/D1\/D1476\/59549038\/gkae859.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T10:52:01Z","timestamp":1736160721000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article\/53\/D1\/D1476\/7808507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":95,"journal-issue":{"issue":"D1","published-print":{"date-parts":[[2025,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkae859","relation":{},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1,6]]},"published":{"date-parts":[[2024,10,3]]}}}